title: Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats.
abstract: During the anabolic response associated with inflammation, mucin synthesis and colonic protection may be compromised by the limited availability of specific amino acids. We therefore determined the effect of dietary amino acid supplementation on the microbiota, mucin status, and mucosal damage in dextran sulfate sodium (DSS)-treated rats. From 8 d before to 28 d after colitis induction, male Sprague-Dawley rats (10 mo old, n = 8/group) were fed a control diet supplemented or not with 2 different doses of an amino acid cocktail containing L-threonine, L-serine, L-proline, and L-cysteine. All diets were isonitrogenous (adjusted with L-alanine). The higher dose of amino acids increased the number of Muc2-containing goblet cells in the surface epithelium of the ulcerated area, stimulated mucin production in the colon, and restored the mucin amino acid composition and mucosal content to healthy, control values. The colonic mucin synthesis rate was specifically stimulated by 95%, whereas the protein turnover was unchanged. All bacterial populations, markedly altered by the DSS treatment, were promoted. In conclusion, in inflammatory situations, an increase in threonine, serine, proline, and cysteine dietary supply can promote mucin synthesis, reequilibrate the gut microbiota, and thus favor colonic protection and mucosal healing.
authors.affiliation: Nestlé Research Center, Nutrition and Health Department, Switzerland. magali.faure@rdls.nestle.com
authors.forename: Magali
authors.initials: M
authors.lastname: Faure
authors.forename: Christine
authors.initials: C
authors.lastname: Mettraux
authors.forename: Denis
authors.initials: D
authors.lastname: Moennoz
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Godin
authors.forename: Jacques
authors.initials: J
authors.lastname: Vuichoud
authors.forename: Florence
authors.initials: F
authors.lastname: Rochat
authors.forename: Denis
authors.initials: D
authors.lastname: Breuillé
authors.forename: Christiane
authors.initials: C
authors.lastname: Obled
authors.forename: Irène
authors.initials: I
authors.lastname: Corthésy-Theulaz
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D003093:Colitis, Ulcerative / Q000517:prevention & control; D016264:Dextran Sulfate / Q000494:pharmacology*; D004195:Disease Models, Animal; D005243:Feces / Q000382:microbiology; D020397:Goblet Cells / Q000187:drug effects / Q000473:pathology*; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects*; D008297:Male; D055262:Mucin-2; D009077:Mucins / Q000096:biosynthesis* / Q000235:genetics; D009929:Organ Size / Q000187:drug effects; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000596:Amino Acids; D000925:Anticoagulants; C524628:Muc2 protein, rat; D055262:Mucin-2; D009077:Mucins; D011506:Proteins; D016264:Dextran Sulfate